Lucid Diagnostics (LUCD) Depreciation & Amortization (CF) (2021 - 2026)
Lucid Diagnostics' (LUCD) quarterly Depreciation & Amortization (CF) came in at $222000.0 in Q1 2026, little changed YoY from $221000.0 in Q1 2025, and up 6.22% on a QoQ basis from $209000.0 in Q4 2025.
Lucid Diagnostics (LUCD) Depreciation & Amortization (CF) (2021 - 2026) Analysis & Trends
Lucid Diagnostics (LUCD) has 6 years of Depreciation & Amortization (CF) data on file, last reported at $222000.0 in Q1 2026.
- Quarterly Depreciation & Amortization (CF) changed 0.45% year-over-year to $222000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $873000.0 (down 1.58% YoY) and the FY2025 annual result came in at $872000.0, down 25.28% from the prior year.
- Depreciation & Amortization (CF) improved to $222000.0 in Q1 2026, from $209000.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $704000.0 in Q2 2022 to a low of $24000.0 in Q1 2022.
- A 5-year average of $393882.4 and a median of $229000.0 in 2024 frame the typical range for Depreciation & Amortization (CF).
- Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) soared 61400.0% — and 2024, when it sank 65.6%.
- Tracing LUCD's Depreciation & Amortization (CF) over 5 years: stood at $615000.0 in 2022, then increased by 2.28% to $629000.0 in 2023, then plunged by 64.71% to $222000.0 in 2024, then fell by 5.86% to $209000.0 in 2025, then increased by 6.22% to $222000.0 in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $222000.0 (Q1 2026), $209000.0 (Q4 2025), and $220000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 355.00 Mn |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | 42.70 Mn |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | 68.20 Mn |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 750.89 Mn |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | 123.80 Mn |
| 10 | Lucid Diagnostics | 176.73 Mn | 143.33 Mn | 55,000.00 | 224,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 224,000.00 |
| Jun 30, 2026 | 224,000.00 |
| Mar 31, 2026 | 222,000.00 |
| Mar 31, 2026 | 222,000.00 |
| Dec 31, 2025 | 209,000.00 |
| Dec 31, 2025 | 209,000.00 |
| Sep 30, 2025 | 220,000.00 |
| Sep 30, 2025 | 220,000.00 |
| Jun 30, 2025 | 222,000.00 |
| Jun 30, 2025 | 222,000.00 |
| Mar 31, 2025 | 221,000.00 |
| Mar 31, 2025 | 221,000.00 |
| Dec 31, 2024 | 222,000.00 |
| Dec 31, 2024 | 222,000.00 |
| Sep 30, 2024 | 215,000.00 |
| Sep 30, 2024 | 215,000.00 |
| Jun 30, 2024 | 229,000.00 |
| Jun 30, 2024 | 229,000.00 |
| Mar 31, 2024 | 501,000.00 |
| Mar 31, 2024 | 501,000.00 |